1,958 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 884 increasing their positions, 762 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9871,958 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 285234 (-51)

Holders
1,958
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$337M
2 +$327M
3 +$270M
4
Renaissance Technologies
Renaissance Technologies
New York
+$231M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$176M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$13.3B
2
$10.5B
3
$5.56B
4
$3.89B
5
$3.84B
6
$3.32B
7
$3.16B
8
$2.79B
9
$2.71B
10
$2.67B
11
$2.44B
12
$2.23B
13
$2.02B
14
$1.99B
15
$1.83B
16
$1.8B
17
$1.7B
18
$1.61B
19
$1.6B
20
$1.53B
21
$1.49B
22
$1.48B
23
$1.38B
24
$1.37B
25
$1.34B